AU2001296554A1 - Fluorescence detection - Google Patents
Fluorescence detectionInfo
- Publication number
- AU2001296554A1 AU2001296554A1 AU2001296554A AU9655401A AU2001296554A1 AU 2001296554 A1 AU2001296554 A1 AU 2001296554A1 AU 2001296554 A AU2001296554 A AU 2001296554A AU 9655401 A AU9655401 A AU 9655401A AU 2001296554 A1 AU2001296554 A1 AU 2001296554A1
- Authority
- AU
- Australia
- Prior art keywords
- fluorescence detection
- fluorescence
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000001917 fluorescence detection Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10351—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/679,439 | 2000-10-04 | ||
| US09/679,439 US6447995B1 (en) | 2000-10-04 | 2000-10-04 | Utilizing intrinsic fluorescence to detect adenovirus |
| PCT/US2001/030980 WO2002029388A2 (en) | 2000-10-04 | 2001-10-04 | Fluorescence detection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001296554A1 true AU2001296554A1 (en) | 2002-04-15 |
Family
ID=24726913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001296554A Abandoned AU2001296554A1 (en) | 2000-10-04 | 2001-10-04 | Fluorescence detection |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US6447995B1 (en) |
| EP (1) | EP1322938A2 (en) |
| AU (1) | AU2001296554A1 (en) |
| WO (1) | WO2002029388A2 (en) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7732129B1 (en) * | 1998-12-01 | 2010-06-08 | Crucell Holland B.V. | Method for the production and purification of adenoviral vectors |
| US6194191B1 (en) * | 1996-11-20 | 2001-02-27 | Introgen Therapeutics, Inc. | Method for the production and purification of adenoviral vectors |
| US20030224354A1 (en) * | 2002-05-30 | 2003-12-04 | Introgen Therapeutics Inc. | Quantifying viral particles with intrinsic fluorescence |
| WO2004068104A2 (en) * | 2003-01-24 | 2004-08-12 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target activated microtransfer |
| US7695752B2 (en) * | 2003-01-24 | 2010-04-13 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target activated microtransfer |
| US20040166091A1 (en) | 2003-02-24 | 2004-08-26 | Genvec, Inc. | Materials and methods for treating disorders of the ear |
| US7060992B1 (en) | 2003-03-10 | 2006-06-13 | Tiax Llc | System and method for bioaerosol discrimination by time-resolved fluorescence |
| ES2391975T3 (en) * | 2003-07-25 | 2012-12-03 | Genvec, Inc. | Adenoviral vector based vaccines |
| US7069191B1 (en) * | 2003-08-06 | 2006-06-27 | Luminex Corporation | Methods for reducing the susceptibility of a peak search to signal noise |
| WO2005051432A1 (en) | 2003-11-14 | 2005-06-09 | Genvec, Inc. | Therapeutic regimen for treating cancer |
| WO2005110492A2 (en) | 2004-04-12 | 2005-11-24 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Method of using adenoviral vectors to induce an immune response |
| US7867707B2 (en) * | 2004-06-11 | 2011-01-11 | Evotec Ag | Method for detecting analytes in a sample |
| WO2006039045A2 (en) * | 2004-09-01 | 2006-04-13 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Adenoviral vectors able to transduce apcs, potential use in immune response generation |
| JP2008518632A (en) * | 2004-11-03 | 2008-06-05 | イントロゲン セラピューティックス， インコーポレイテッド | A novel method for the production and purification of adenoviral vectors |
| EP1869206A4 (en) * | 2005-03-02 | 2011-08-10 | Einstein Coll Med | ENZYMATIC SENSORS COMPRISING ENVIRONMENTALLY OR FLUORESCENTLY SENSITIVE LABELS AND USES THEREOF |
| US9651543B2 (en) | 2005-08-31 | 2017-05-16 | The United States Of America As Represented By The Secretary Of The Navy | Malaria antigen screening method |
| US8450055B2 (en) | 2005-08-31 | 2013-05-28 | The United States Of America As Represented By The Secretary Of The Navy | Malaria antigen screening method |
| NZ542230A (en) * | 2005-09-05 | 2008-05-30 | Veritide Ltd | System for spore detection |
| US7622723B2 (en) * | 2005-09-23 | 2009-11-24 | Veritide Limited | System for spore detection |
| BRPI0618441B8 (en) * | 2005-11-10 | 2021-07-27 | Genvec Inc | adenoviral vector |
| US8454895B2 (en) * | 2007-05-03 | 2013-06-04 | Nanyang Technological University | Online contaminant detection and removal system |
| US9605844B2 (en) * | 2009-09-01 | 2017-03-28 | Cree, Inc. | Lighting device with heat dissipation elements |
| US9157921B2 (en) * | 2011-05-18 | 2015-10-13 | Purdue Research Foundation | Method for diagnosing abnormality in tissue samples by combination of mass spectral and optical imaging |
| BR112017001601A2 (en) | 2014-09-07 | 2017-11-21 | Selecta Biosciences Inc | methods and compositions for attenuating immune responses of the modulating antiviral transfer vector of gene expression |
| TWI710635B (en) | 2014-10-09 | 2020-11-21 | 美商珍維克公司 | Adenoviral vector encoding human atonal homolog-1 (hath1) |
| KR20240015743A (en) | 2017-01-07 | 2024-02-05 | 셀렉타 바이오사이언시즈, 인크. | Patterned dosing of immunosuppressants coupled to synthetic nanocarriers |
| EP3694543A1 (en) | 2017-10-13 | 2020-08-19 | Selecta Biosciences, Inc. | Methods and compositions for attenuating anti-viral transfer vector igm responses |
| CN114126666A (en) | 2019-04-28 | 2022-03-01 | 西莱克塔生物科技公司 | Methods for treating subjects with pre-existing immunity to viral transfer vectors |
| KR20220015425A (en) | 2019-05-28 | 2022-02-08 | 셀렉타 바이오사이언시즈, 인크. | Methods and compositions for attenuated antiviral transfer vector immune response |
| CN114981298B (en) | 2019-12-12 | 2024-08-20 | 听治疗有限责任公司 | Compositions and methods for preventing and treating hearing loss |
| US20230141563A1 (en) | 2021-10-12 | 2023-05-11 | Selecta Biosciences, Inc. | Methods and compositions for attenuating anti-viral transfer vector igm responses |
| US20230357437A1 (en) | 2022-03-09 | 2023-11-09 | Selecta Biosciences, Inc. | Immunosuppressants in combination with anti-igm agents and related dosing |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3887812A (en) | 1973-07-02 | 1975-06-03 | Block Engineering | Method and apparatus for detecting and classifying nucleic acid particles |
| US4222743A (en) | 1978-07-20 | 1980-09-16 | Wang Wei Kung | Method and apparatus for detecting biological particles by fluorescent stain |
| WO1990013808A1 (en) | 1989-05-01 | 1990-11-15 | Byk Gulden Lomberg Chem Fab | Reflection fluorimeter |
| US4979824A (en) | 1989-05-26 | 1990-12-25 | Board Of Trustees Of The Leland Stanford Junior University | High sensitivity fluorescent single particle and single molecule detection apparatus and method |
| WO1991009310A1 (en) | 1989-12-12 | 1991-06-27 | Lidak Pharmaceuticals | Free fatty acid determination |
| DE69326967T2 (en) | 1992-01-17 | 2000-06-15 | Lakowicz, Joseph R. | Phase modulation energy transfer fluoroimmunoassay |
| US5323008A (en) | 1992-03-23 | 1994-06-21 | Diatron Corporation | Fluorometer detection system |
| US5733720A (en) | 1992-06-18 | 1998-03-31 | Washington University | Genetically engineered cell lines for detecting infectious herpesvirus and methods therefor |
| EP0662153A1 (en) | 1992-07-17 | 1995-07-12 | Aprogenex, Inc. | Free radical scavengers useful for reducing autofluorescence in fixed cells |
| US5733721A (en) | 1992-11-20 | 1998-03-31 | The Board Of Regents Of The University Of Oklahoma | Cell analysis method using quantitative fluorescence image analysis |
| US5604096A (en) | 1993-03-04 | 1997-02-18 | Schaeffer; Warren I. | Fluorometric quantitation of mycoplasmas |
| AU6945694A (en) | 1993-05-06 | 1994-12-12 | Dade International Inc. | Human papillomavirus detection assay |
| US5421339A (en) | 1993-05-12 | 1995-06-06 | Board Of Regents, The University Of Texas System | Diagnosis of dysplasia using laser induced fluoroescence |
| US5837520A (en) | 1995-03-07 | 1998-11-17 | Canji, Inc. | Method of purification of viral vectors |
| US5895922A (en) | 1996-03-19 | 1999-04-20 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence | Fluorescent biological particle detection system |
| JPH09262099A (en) | 1996-03-28 | 1997-10-07 | Aisin Seiki Co Ltd | Method for detecting nucleic acid etc. by fluorescein derivative phosphate ester |
| TW371617B (en) | 1996-10-09 | 1999-10-11 | Of Animal And Plant Health Inspection And Quarantine Council Of Agriculture Executive Yuan Bureau | Method to transplant GFP into autographa californica multiple nuclear polyhedrosis virus for inflicting pest in an attempt to detect and flow up it existence and to improve life span against UV |
| US6130313A (en) | 1997-10-02 | 2000-10-10 | Clontech Laboratories, Inc. | Rapidly degrading GFP-fusion proteins |
| US5922576A (en) | 1998-02-27 | 1999-07-13 | The John Hopkins University | Simplified system for generating recombinant adenoviruses |
| JP2002505866A (en) | 1998-03-10 | 2002-02-26 | ラージ・スケール・プローティオーミックス・コーポレイション | Microbial detection and characterization |
| US6265151B1 (en) | 1998-03-27 | 2001-07-24 | Seroptix, Inc. | Apparatus and method for infectious disease detection |
| HUP0102209A2 (en) | 1998-04-22 | 2001-09-28 | Genvec, Inc. | Procedure for effective purification of adenovirus |
| WO1999060371A2 (en) | 1998-05-15 | 1999-11-25 | Geron Corporation | Method and apparatus for detecting hazardous agents |
| GB9816761D0 (en) | 1998-07-31 | 1998-09-30 | Phogen Limited | Herpesvirus preparations and their uses |
| EP1102977A1 (en) | 1998-08-08 | 2001-05-30 | Imperial Cancer Research Technology Limited | Fluorescence assay for biological systems |
| US5965358A (en) | 1998-08-26 | 1999-10-12 | Genvec, Inc. | Method for assessing the relative purity of viral gene transfer vector stocks |
| CA2252972C (en) | 1998-11-26 | 2012-09-18 | National Research Council Of Canada | Serum-free production of recombinant proteins and adenoviral vectors |
| JP2003523169A (en) | 1998-12-31 | 2003-08-05 | アバンテイス・フアルマ・エス・アー | Virus particle isolation method |
-
2000
- 2000-10-04 US US09/679,439 patent/US6447995B1/en not_active Expired - Lifetime
-
2001
- 2001-06-25 US US09/888,681 patent/US6630299B2/en not_active Expired - Lifetime
- 2001-10-04 WO PCT/US2001/030980 patent/WO2002029388A2/en not_active Application Discontinuation
- 2001-10-04 EP EP01977436A patent/EP1322938A2/en not_active Withdrawn
- 2001-10-04 AU AU2001296554A patent/AU2001296554A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US6630299B2 (en) | 2003-10-07 |
| US20020045160A1 (en) | 2002-04-18 |
| WO2002029388A3 (en) | 2002-12-27 |
| US6447995B1 (en) | 2002-09-10 |
| WO2002029388A2 (en) | 2002-04-11 |
| EP1322938A2 (en) | 2003-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001296554A1 (en) | Fluorescence detection | |
| AU2002225807A1 (en) | Object detection | |
| AU2001293998A1 (en) | Detection system | |
| AU2001294989A1 (en) | Speech detection | |
| AU2001254546A1 (en) | Aminopiperidines | |
| AU2000267458A1 (en) | Hypercomputer | |
| AU2001220246A1 (en) | Neckphone | |
| AU2001239310A1 (en) | Decahydro-isoquinolines | |
| AU2001258349A1 (en) | Bisacylguanidine | |
| AU2001272762A1 (en) | Photomultiplier | |
| AU2001272764A1 (en) | Photomultiplier | |
| AU2001281633A1 (en) | Detection method | |
| AU2001283890A1 (en) | Window detection | |
| AU2001258924A1 (en) | Microsatellite-aflp | |
| AUPR050700A0 (en) | Detection method | |
| AUPQ667800A0 (en) | Detection method | |
| AUPQ664300A0 (en) | Macromolecule detection | |
| AU2001272763A1 (en) | Photomultiplier | |
| AU2001232041A1 (en) | Improved assay | |
| AU2001246864A1 (en) | Hypotensors | |
| AU2001226668A1 (en) | Crankshaft-starter-generator | |
| AU2001292922A1 (en) | Nucleic acid detection | |
| AU2001287754A1 (en) | Impactor | |
| AU2001260192A1 (en) | Glycinamides | |
| AU2001262711A1 (en) | Cytoprotectors |